200 results on '"Patt, Yehuda Z."'
Search Results
2. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer
3. A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
4. A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma
5. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction
6. Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer
7. Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
8. Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy
9. Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States#
10. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case-control study
11. Colorectal carcinoma and brain metastasis: Distribution, treatment, and survival
12. Epidemiology and Molecular Epidemiology of Hepatocellular Cancer
13. Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Metastatic Hepatocellular Carcinoma
14. Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case–Control Study
15. Thalidomide in the treatment of patients with hepatocellular carcinoma: A Phase II trial
16. Oral Capecitabine for the Treatment of Hepatocellular Carcinoma, Cholangiocarcinoma, and Gallbladder Carcinoma
17. Phase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma
18. Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma
19. Capecitabine and irinotecan combination in first line metastatic colorectal cancer (MCRC) patients (pts): Initial results of a multicenter phase II trial
20. Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma
21. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer
22. Phase II study of didemnin B in advanced colorectal cancer
23. Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas
24. Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma
25. Percutaneous Transcatheter Arterial Embolization for Hypersplenism
26. LIVER CANCER
27. Nonsurgical Treatment of Hepatocellular Carcinoma
28. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
29. A Phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver
30. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen: experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials
31. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma
32. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer
33. Hepatic Arterial Infusion of Floxuridine, Adriamycin, and Mitomycin C for Primary Liver Neoplasms
34. Regional Arterial Therapy in the Management of Primary Liver Neoplasms
35. INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial
36. Phase two clinical trial of combination oxaliplatin, irinotecan, and cetuximab for patients with locally advanced or metastatic pancreatic cancer.
37. Ethnicity and hepatocellular carcinoma risk factors in New Mexico: A retrospective analysis over a 12-year period.
38. Association between the job types and the risk of hepatocellular carcinoma in the United States
39. Modified Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability and survival of initially unresectable hepatocellular carcinoma
40. The need for immune evaluation prior to thymosin-containing chemoimmunotherapy for melanoma
41. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.
42. Treatment of Hepatocellular Carcinoma in the Community: Disparities in Standard Therapy
43. Original Article A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
44. TREATMENT OF REGIONALLY CONFINED METASTATIC TUMORS WITH ARTERIAL INFUSION OF CISPLATIN
45. CONTRIBUTORS
46. Hepatic Arterial Infusion of Chemotherapy for Metastatic Colorectal Cancer in the Liver: Why, How and What?
47. Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts).
48. A phase II trial of combination oxaliplatin, capecitabine, and celecoxib with concurrent radiation for patients with newly diagnosed resectable rectal cancer.
49. A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard)
50. Phase II trial of sorafenib and capecitabine for hepatocellular carcinoma in cirrhotic patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.